GIVN 📈 Givaudan SA - Overview

Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0010645932

GIVN: Fragrances, Beauty Products, Flavours, Beverages, Snacks, Supplements

Givaudan SA is a leading manufacturer and supplier of fragrance, beauty, taste, and wellbeing products, catering to the diverse needs of the consumer goods industry. The company's operations are divided into two primary divisions: Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division specializes in the creation of fine fragrances, as well as a range of consumer products, including personal care items, home care products, fabric care, and oral care. Additionally, this division offers fragrance ingredients and active beauty products, which are used by various companies to create their own branded products.

The Taste & Wellbeing division, on the other hand, focuses on the development of flavor solutions for a wide range of food and beverage products. This includes beverages such as carbonated drinks, bottled water, and ready-to-drink juices, as well as dairy and cheese products like yoghurt, ice cream, and cream cheese. The division also provides flavor ingredients for snacks, savory products, and supplements, as well as biscuits, crackers, cereals, and confectionery products like chewing gum, chocolate, and sweets. With a presence in multiple regions, including Switzerland, Europe, Africa, the Middle East, North America, Latin America, and the Asia Pacific, Givaudan SA has established itself as a global player in the specialty chemicals industry.

Founded in 1796, Givaudan SA has a rich history that spans over two centuries. Headquartered in Vernier, Switzerland, the company has evolved over the years to become a leading provider of fragrance and flavor solutions. With a strong commitment to innovation and customer satisfaction, Givaudan SA continues to expand its product portfolio and geographical reach, making it an attractive option for investors and customers alike. The company's common stock is listed under the ISIN code CH0010645932, and it is classified under the Specialty Chemicals sub-industry, according to the Global Industry Classification Standard (GICS).

Additional Sources for GIVN Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

GIVN Stock Overview

Market Cap in USD 41,378m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Specialty Chemicals
IPO / Inception

GIVN Stock Ratings

Growth 5y 28.6%
Fundamental 78.0%
Dividend 52.5%
Rel. Strength Industry 1371
Analysts -
Fair Price Momentum 3822.82 CHF
Fair Price DCF 5532.54 CHF

GIVN Dividends

Dividend Yield 12m 1.71%
Yield on Cost 5y 2.47%
Annual Growth 5y 1.96%
Payout Consistency 97.1%

GIVN Growth Ratios

Growth Correlation 3m -71.8%
Growth Correlation 12m 50.7%
Growth Correlation 5y 16.9%
CAGR 5y 7.62%
CAGR/Mean DD 5y 0.45
Sharpe Ratio 12m 0.72
Alpha 2.53
Beta 0.47
Volatility 19.86%
Current Volume 9.5k
Average Volume 20d 18.3k
What is the price of GIVN stocks?
As of December 30, 2024, the stock is trading at CHF 3982.00 with a total of 9,505 shares traded.
Over the past week, the price has changed by +0.84%, over one month by +2.60%, over three months by -14.18% and over the past year by +16.22%.
Is Givaudan SA a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Givaudan SA (SW:GIVN) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 78.00 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GIVN as of December 2024 is 3822.82. This means that GIVN is currently overvalued and has a potential downside of -4%.
Is GIVN a buy, sell or hold?
Givaudan SA has no consensus analysts rating.
What are the forecast for GIVN stock price target?
According to ValueRays Forecast Model, GIVN Givaudan SA will be worth about 4156.6 in December 2025. The stock is currently trading at 3982.00. This means that the stock has a potential upside of +4.38%.
Issuer Forecast Upside
Wallstreet Target Price 4176.3 4.9%
Analysts Target Price - -
ValueRay Target Price 4156.6 4.4%